Concepedia

Scott A. Becka

SA

Statistics

Publications

14

Citations

497

H-Index

13

Active since

2015

Affiliations

Case Western Reserve University(Current)

Louis Stokes Cleveland VA Medical Center

University of Michigan

J. Craig Venter Institute

Northeast Health

Scott A. Becka is an author at Case Western Reserve University specializing in antibiotics, mass spectrometry, and clinical microbiology.

Top concepts

Publications per year

2015–2021

14

Publications

14

Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae

Krisztina M. Papp‐Wallace, Melissa D. Barnes, Jim Alsop et al. · Antimicrobial Agents and Chemotherapy · 2018 · 94 citations · Full text

, , +20

Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for <i>Burkholderia cepacia</i> Complex Isolates from Cystic Fibrosis Patients

Krisztina M. Papp‐Wallace, Scott A. Becka, Elise T. Zeiser et al. · ACS Infectious Diseases · 2017 · 75 citations · Full text

Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa

Krisztina M. Papp‐Wallace, Elise T. Zeiser, Scott A. Becka et al. · The Journal of Infectious Diseases · 2019 · 70 citations · Full text

Cerebrospinal fluid (CSF) augments metabolism and virulence expression factors in Acinetobacter baumannii

Jasmine Martinez, Chelsea Razo-Gutierrez, Casin Le et al. · Scientific Reports · 2021 · 47 citations · Full text

Inactivation of the Pseudomonas-Derived Cephalosporinase-3 (PDC-3) by Relebactam

Melissa D. Barnes, Christopher R. Bethel, Jim Alsop et al. · Antimicrobial Agents and Chemotherapy · 2018 · 36 citations · Full text

Rows per page

1–5 of 14